Importantly, as expected, antithrombin-III (SERPINC1) and zinc-α-2-glycoprotein (AZGP1), possible monitoring proteins for surgery for CAS, were not included in the proteins that are differentially expressed in presurgical and postsurgical sera of AAA and TAA patients but were unique to those for CAS patients. This evidence concerns the gene AZGP1 and triple-A syndrome.